Metabotropic Glutamate Receptor 5 as a Target for the Treatment of Depression and Smoking: Robust Preclinical Data but Inconclusive Clinical Efficacy. [electronic resource]
Producer: 20190909Description: 955-962 p. digitalISSN:- 1873-2402
- Animals
- Depressive Disorder, Major -- drug therapy
- Drug Discovery
- Excitatory Amino Acid Antagonists -- administration & dosage
- Humans
- Randomized Controlled Trials as Topic
- Receptor, Metabotropic Glutamate 5 -- agonists
- Smoking -- drug therapy
- Synaptic Transmission -- drug effects
- Tobacco Use Disorder -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.